Protagonist Therapeutics PTGX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's operating lease ROU assets?
- Protagonist Therapeutics (PTGX) reported operating lease ROU assets of $7.39M in Q1 2026.
- How has Protagonist Therapeutics's operating lease ROU assets changed year-over-year?
- Protagonist Therapeutics's operating lease ROU assets decreased by 17.9% year-over-year, from $9M to $7.39M.
- What is the long-term trend for Protagonist Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's operating lease ROU assets has grown at a 9.6% compound annual growth rate (CAGR), from $4.95M to $7.83M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.